Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood

European Journal of Endocrinology

Volumn 135, Issue 4, 1996, Pages 421-424

  Bellone, J ^a   Aimaretti, G ^a   Valetto, M R ^a   Bellone, S ^a   Baffoni, C ^a   Arvat, E ^a   Seminara, S ^b   Camanni, F ^a   Ghigo, E ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SERMORELIN; SOMATOSTATIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; SOMATOSTATIN RELEASE;

EID: 0029989882     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350421     Document Type: Article

References (33)

1. Tannenbaum GS, Ling N. The interrelationship of GH-releasing factor and somatostatin in the generation of the ultradian rhythm of GH secretion. Endocrinology 1984;115:1952-60
2. Muller EE, Nistico' G. Brain messenger and the pituitary. San Diego: Academic Press, 1989
3. Hartman ML, Veldhuis JD, Thorner MO. Normal control of growth hormone secretion. Horm Res. 1993;40:37-47
4. Ghigo E. Neurotransmitter control of growth hormone secretion. In: de la Cruz FF, editor. Regulation of growth hormone and somatic growth. Amsterdam: Elsevier Science Publishers, 1989:103-6
5. Casanueva FF. Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Am 1992;21:483-517
6. Tannenbaum GS. Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology 1980;107:2117-20
7. Tannenbaum GS, Guyda HJ, Posner BI. Insulin-like growth factors: a role in growth hormone negative feed-back and body weight regulation via brain. Science 1983;220:77-9
8. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL. Somatomedin-C mediates growth hormone negative feedback by effects on both hypothalamus and the pituitary. Science 1981;212:1279-81
9. Massara F, Ghigo E, Molinatti P, Mazza E, Locatelli V, Molinatti GM, et al. Potentiation of cholinergic tone by pyridostigmine bromide reinstates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol (Copenh) 1986;113:12-6
10. Ross RJM, Borges F, Grossman A, Smith R, Ngahfoong L, Lesley, H, et al. Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone: evidence for a direct effect of growth hormone. Clin Endocrinol 1987:26: 117-23
11. Ross RJM, Tsagarakis S, Grossman A, Nhagafoong L, Touzel RJ, Rees LH, et al. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clin Endocrinol 1987;27: 727-33
12. Rosenbaum M, Leibel RL, Gertner JM. Acute inhibition of somatotroph response to human growth hormone-releasing hormone 1-44 occurs following three hours but not one hour of growth hormone infusion. Metabolism 1989;38:590-3
13. Rosenthal SM, Kaplan SL, Grumbach MM. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect. J Clin Endocrinol Metab 1989;68:1101-5
14. Sartorio A, Spada A, Morabito F, Faglia G. Different GH responsiveness to repeated GHRH administration in normal children and adults. J Endocrinol Invest 1988;11:727-9
15. Ghigo E, Goffi S, Mazza E, Arvat E, Procopio M, Bellone J, et al. Repeated GH-releasing hormone administration unravels different GH secretory patterns in normal adults and children. Acta Endocrinol (Copenh) 1989;120:598-601
16. Ghigo E, Goffi S, Nicolosi M, Arvat E, Procopio M, Bellone J, et al. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 1990;71:1481-5
17. Ghigo E, Arvat E, Goffi S, Bellone J, Valente F, Procopio M, et al. Repetitive GHRH and arginine administration to explore the maximal secretory capacity of somatotroph cells during lifespan. Exp Clin Endocrinol (Life Sci Adv) 1991;10:191-8
18. Alba-Roth J, Albrecht Muller O, Schopohl J, Von Werder K. Arginine stimulates GH secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 1988:67: 1186-9
19. Page MD, Dieguez C, Valcavi R, Edwards C, Hak R, Scanlon MF. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment. Clin Endocrinol 1988;28:551-8
20. Ghigo E, Bellone J, Mazza E, Imperiale E, Valente F, Lala R, et al. Arginine potentiate the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol 1990;32:763-7
21. Ghigo E, Arvat E, Valente F, Nicolosi M, Boffano GM, Procopio M, et al. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 1991;54:291-4
22. Pontiroli AE, Lanzi R, Pozza G. Inhibition of the growth hormone (GH) response to GH-releasing hormone by constant met-GH infusions. J Clin Endocrinol Metab 1989;68:956-9
23. Lanzi R, Tannenbaum GS. Time-dependent reduction and potentation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin. Endocrinology 1992;130:1822-8
24. Losa M, Boch L, Schopohl J, Stalla GK, Muller OA, Von Werder K. Growth hormone-releasing factor infusion does not sustain elevated GH levels in normal subjects. Acta Endocrinol (Copenh) 1984;107:462-70
25. Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Demura H, et al. Plasma GH responses to GHRH and insulin-induced hypoglycaemia in man. J Clin Endocrinol Metab 1985;60: 1265-7
26. Arosio M, Losa M, Bazzoni N, Bocchicchio D, Palmieri E, Nava C, et al. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulation in normal subjects. Acta Endocrinol (Copenh) 1990;122:135-9
27. Arvat E, Ghigo E, Nicolosi M, Boffano GM, Bellone J, Yin-Zhang W, et al. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man. Clin Endocrinol 1992;36:347-50
28. Suri D, Hindmarsh PC, Mattews DR, Brain CE, Brook CGD. The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH). Clin Endocrinol (Oxf) 1991;34:13-7
29. Weherenberg WB, Brazeau P, Ling N, Textore G, Guillemin R. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor. Endocrinology 1984;114:1613-9
30. Chanoine JP, Vanderschueren-Lodeweyckx Maes M. Thiry-Counson G, Craen M, Van Vliet G. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeed-back. J Clin Endocrinol Metab 1991;73:1269-75
31. Nakamoto JM, Gestner JM, Press CM, Hintz RL, Rosenfeld RG, Genel M. Suppression of the growth hormone response to clonidine and GH-releasing hormone by exogenous GH. J Clin Endocrinol Metab 1986;62:822-5
32. Hanew K, Goh M, Sato S, Shimizu Y, Sasaki A, Aida M, et al. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency. J Clin Endocrinol Metab 1988;66:715-21
33. Mouhieddine OEB, Levy L, Benlot C, Peillon F, Joubert D. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumours. J Clin Endocrinol Metab 1995;80:1691-5